Abstract
Biotechnology Law ReportVol. 21, No. 3 Single-Patient Access to Investigational Drugs: Friend or Foe?Juliana MoreheadJuliana MoreheadSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/073003102760162309AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byCerium Nitrate Treatment in the Management of Burns Romina Deldar, Peter D'Arpa, Lauren Moffatt, Kai Leung, and Jeffrey Shupp13 May 2022 | Advances in Wound Care, Vol. 11, No. 8Just Say No to Drugs: The Abigail Alliance and the Attempted Abolition of the Food and Drug Administration Leif N. Furmansky30 April 2007 | Biotechnology Law Report, Vol. 26, No. 2 Volume 21Issue 3Jun 2002 To cite this article:Juliana Morehead.Single-Patient Access to Investigational Drugs: Friend or Foe?.Biotechnology Law Report.Jun 2002.231-248.http://doi.org/10.1089/073003102760162309Published in Volume: 21 Issue 3: July 5, 2004PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
